Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

15 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Response to: 'Calprotectin is not independent from baseline erosion in predicting radiological progression in early rheumatoid arthritis' by Chevreau et al.
Jonsson MK, Sundlisæter NP, Nordal HH, Hammer HB, Aga AB, van der Heijde D, Kvien TK, Fevang BS, Lillegraven S, Haavardsholm EA. Jonsson MK, et al. Among authors: fevang bs. Ann Rheum Dis. 2018 Dec;77(12):e85. doi: 10.1136/annrheumdis-2017-212869. Epub 2018 Jan 10. Ann Rheum Dis. 2018. PMID: 29321158 No abstract available.
Calprotectin as a marker of inflammation in patients with early rheumatoid arthritis.
Jonsson MK, Sundlisæter NP, Nordal HH, Hammer HB, Aga AB, Olsen IC, Brokstad KA, van der Heijde D, Kvien TK, Fevang BS, Lillegraven S, Haavardsholm EA. Jonsson MK, et al. Among authors: fevang bs. Ann Rheum Dis. 2017 Dec;76(12):2031-2037. doi: 10.1136/annrheumdis-2017-211695. Epub 2017 Aug 16. Ann Rheum Dis. 2017. PMID: 28814431 Clinical Trial.
The role of anti-citrullinated protein antibody reactivities in an inception cohort of patients with rheumatoid arthritis receiving treat-to-target therapy.
Jonsson MK, Hensvold AH, Hansson M, Aga AB, Sexton J, Mathsson-Alm L, Cornillet M, Serre G, Lillegraven S, Fevang BS, Catrina AI, Haavardsholm EA. Jonsson MK, et al. Among authors: fevang bs. Arthritis Res Ther. 2018 Jul 13;20(1):146. doi: 10.1186/s13075-018-1635-7. Arthritis Res Ther. 2018. PMID: 30001740 Free PMC article. Clinical Trial.
Differential sensitivity of the 2020 revised comprehensive diagnostic criteria and the 2019 ACR/EULAR classification criteria across IgG4-related disease phenotypes: results from a Norwegian cohort.
Vikse J, Midtvedt Ø, Fevang BS, Garen T, Palm Ø, Wallenius M, Bakland G, Norheim KB, Molberg Ø, Hoffmann-Vold AM. Vikse J, et al. Among authors: fevang bs. Arthritis Res Ther. 2023 Sep 5;25(1):163. doi: 10.1186/s13075-023-03155-y. Arthritis Res Ther. 2023. PMID: 37670401 Free PMC article.
15 results